Norris Medicines reports standalone net loss of Rs 0.44 crore in the June 2022 quarter
Sales decline 80.57% to Rs 0.95 crore
Net Loss of Norris Medicines reported to Rs 0.44 crore in the quarter ended June 2022 as against net loss of Rs 0.05 crore during the previous quarter ended June 2021. Sales declined 80.57% to Rs 0.95 crore in the quarter ended June 2022 as against Rs 4.89 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales0.954.89 -81 OPM %-21.0510.43 -PBDT-0.290.11 PL PBT-0.44-0.05 -780 NP-0.44-0.05 -780Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content